Uploaded February 2024 | Updated November 2026, 9 hours ago
Nancy J. Cox, PhD, is Professor of Medicine and Director of the Division of Genetic Medicine within the Department of Medicine at Vanderbilt University Medical Center. Dr. Cox completed her PhD at Yale University and conducted postdoctoral research at Washington University and the University of Pennsylvania. She joined the faculty at the University of Chicago, where she spent her academic faculty career until she was recruited to Vanderbilt in 2015 to lead the new Vanderbilt Genetics Institute (VGI). As Founding Director of the VGI, Dr. Cox is focused on recruiting world-class genetics and genomics scientists to the Institute, with the primary goal of making Vanderbilt’s DNA databank, BioVU, into an unparalleled engine for discovery and translation in human genetics and genomics. She initiated the first large-scale genetic/genomic consortium in type 2 diabetes, and she has active research and advisory roles in many of the top genomic consortia that provide the foundation for current studies in human genetics and genomics. Dr. Cox has an active research program in data integration, particularly in the integration of functional genomic information to aid in discovery and interpretation of associations of genome variation with common disease. Her lab was the first to show that most of the common variant associations to common human diseases and complex human traits appear to be regulatory in function. Dr. Cox has more than 280 peer-reviewed publications and was a co-winner of the 2008 American Association of Cancer Research Landon Award and winner of the 2010 Leadership Award in Genetic Epidemiology. She was named a Pritzker Scholar in 2012 and a Distinguished Faculty from the Biological Sciences Division at the University of Chicago in 2013. She is former editor of Genetic Epidemiology (2006-2011), a former member of the Board of Directors for the American Society of Human Genetics, and is Member-at-Large for Biological Sciences in the American Association for the Advancement of Science.
For more information go to oir.nih.gov/wals
Nancy J. Cox, PhD, is Professor of Medicine and Director of the Division of Genetic Medicine within the Department of Medicine at Vanderbilt University Medical Center. Dr. Cox completed her PhD at Yale University and conducted postdoctoral research at Washington University and the University of Pennsylvania. She joined the faculty at the University of Chicago, where she spent her academic faculty career until she was recruited to Vanderbilt in 2015 to lead the new Vanderbilt Genetics Institute (VGI). As Founding Director of the VGI, Dr. Cox is focused on recruiting world-class genetics and genomics scientists to the Institute, with the primary goal of making Vanderbilt’s DNA databank, BioVU, into an unparalleled engine for discovery and translation in human genetics and genomics. She initiated the first large-scale genetic/genomic consortium in type 2 diabetes, and she has active research and advisory roles in many of the top genomic consortia that provide the foundation for current studies in human genetics and genomics. Dr. Cox has an active research program in data integration, particularly in the integration of functional genomic information to aid in discovery and interpretation of associations of genome variation with common disease. Her lab was the first to show that most of the common variant associations to common human diseases and complex human traits appear to be regulatory in function. Dr. Cox has more than 280 peer-reviewed publications and was a co-winner of the 2008 American Association of Cancer Research Landon Award and winner of the 2010 Leadership Award in Genetic Epidemiology. She was named a Pritzker Scholar in 2012 and a Distinguished Faculty from the Biological Sciences Division at the University of Chicago in 2013. She is former editor of Genetic Epidemiology (2006-2011), a former member of the Board of Directors for the American Society of Human Genetics, and is Member-at-Large for Biological Sciences in the American Association for the Advancement of Science.
For more information go to oir.nih.gov/wals
![In Vitro Approaches to Investigate Cell Division and Biological Size Control
Air date: Wednesday, April 27, 2022, 3PM
Description: Wednesday Afternoon Lecture Series [WALS]
Dr. Heald is a professor of cell and developmental biology in the UC Berkeley Department of Molecular and Cell Biology. A member of the National Academy of Sciences, she is recognized for her work on biological size control and her use of cytoplasmic extracts prepared from eggs of the African clawed frog Xenopus laevis to study how the mitotic spindle forms and scales to different sizes.
For this lecture, Dr. Heald will discuss the power of amphibian systems for investigating molecular mechanisms underlying fundamental biological processes including cell division, size scaling across and within species, physiological effects of genome size, and hybrid incompatibility that underlies speciation.
For more information go to https://oir.nih.gov/wals
Author: Rebecca Heald, Ph.D., Professor, Department of Molecular & Cell Biology, University of California, Berkeley
Permanent link: https://videocast.nih.gov/watch=44253 In Vitro Approaches to Investigate Cell Division and Biological Size Control](https://i.ytimg.com/vi/MqckH7AIoN8/mqdefault.jpg)









